Simply Good Foods Posts Mixed Q2 Results; Hopes On Protein Shake Developed For Consumers On Weight-loss Drug

Simply Good Foods beats Q2 earnings, plans Atkins revitalization and protein shake launch for weight-loss drug users, despite revenue miss.

The Simply Good Foods Company (NASDAQ:SMPL) reported second-quarter adjusted earnings per share of 40 cents per share, beating the analyst consensus of 38 cents.

Quarterly revenues of $312.199 million missed the Wall Street View of $316.885 million. Sales rose 5.3% year over year.

Adjusted EBITDA in the quarter under review was $57.8 million versus $50.9 million in the year-ago period. 

“Work is progressing on the Atkins revitalization plan and, as previously discussed, all elements of the plan should be in the marketplace in fiscal 2025,” said Geoff Tanner, President, and Chief Executive Officer of Simply Good Foods. 

Gross profit was $116.9 million for the second quarter of fiscal 2024. Margins expanded 280 basis points to 37.4% in the second quarter.

At the end of the second quarter of fiscal 2024, the company had cash of $135.9 million. 

“We are particularly pleased with the upcoming launch of Atkins Strong, a 30g protein shake developed for consumers on a weight-loss drug or shoppers seeking higher levels of protein,” Tanner added.

Outlook: Simply Good Foods sees FY24 sales to increase around the mid-point of the company’s long-term algorithm of 4%-6% (prior view: high end of the company’s long-term algorithm of 4%-6%).

Adjusted EBITDA is now anticipated to increase 6%-8% (prior view: slightly greater than the net sales growth rate).

Price Action: SMPL shares are trading lower by 0.66% to $32.38 on the last check Thursday.

Total
0
Shares
Related Posts
Read More

Fed-Funded Study Finds Increase In Medical Marijuana Patient Enrollments, Chronic Pain Most Common Reason

The state-legal medical marijuana programs nationwide have seen an uptick in the number of new patients enrolled since 2020, according to newly published federal research in the journal Annals of Internal Medicine. The study, conducted by the Center for Disease Control and Prevention (CDC), the Department of Veterans Affairs (VA) and the University of Michigan showed that there were 4.1 million registered medical cannabis patients in 2022 countrywide, compared to 3.1 million in 2020. That's a 33.3% increase over two years. The researchers proposed that the increase is simultaneous with "increasing cultural acceptance of cannabis, recognition of the harm of the ‘war on drugs' (for example, mass incarceration and related consequences, such as family separation, trauma, and economic loss), and interest in the potential therapeutic properties of cannabis," reported Marijuana Moment.

TLRY